Path: not-for-mail
Message-Id: <Qkk737iQUUKOsXPoaVzasuytvxA@jntp>
Jntp-Route: news2.nemoweb.net
Jntp-Datatype: Article
Subject: Vaccins Covid-19 et syndrome de =?UTF-8?Q?Guillain-Barr=C3=A9?=
Newsgroups: fr.misc.actualite.covid19
Jntp-Hashclient: zNF9yLpKkbWYX_7YbHDR9KfYugY
Jntp-Threadid: FacOVlu5KgL7dSjOn4vdVrOtvFM
Jntp-Uri: http://news2.nemoweb.net/?DataID=Qkk737iQUUKOsXPoaVzasuytvxA@jntp
User-Agent: Nemo/0.999a
Jntp-Originserver: news2.nemoweb.net
Date: Thu, 12 Oct 23 07:01:00 +0000
Organization: Nemoweb
Jntp-Browser: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:109.0) Gecko/20100101 Firefox/118.0
Injection-Info: news2.nemoweb.net; posting-host="48db87d9176ce6969124ceb9d6b05e62333c6c22"; logging-data="2023-10-12T07:01:00Z/8293478"; posting-account="2@news2.nemoweb.net"; mail-complaints-to="newsmaster@news2.nemoweb.net"
Jntp-Protocolversion: 0.21.1
Jntp-Server: PhpNemoServer/0.94.5
Mime-Version: 1.0
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
X-Jntp-Jsonnewsgateway: 0.96
From: Duzz' <jsuis@jreste.invalid>

Les vaccins à ARNm n'augmentent pas le risque de syndrome de 
Guillain-Barré, à la différence des vaccins à vecteur adénoviral :
<https://ansm.sante.fr/actualites/les-vaccins-a-arnm-naugmentent-pas-le-risque-de-syndrome-de-guillain-barre-a-la-difference-des-vaccins-a-vecteur-adenoviral>

Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines :
<https://n.neurology.org/content/early/2023/10/03/WNL.0000000000207847>

Publication EPI-PHARE :
<https://ansm.sante.fr/uploads/2023/10/11/20231011-epi-phare-rapport-guillain-barre.pdf>